# Specification Quality Checklist: Consultar y exportar informe

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-11-02
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- Las decisiones de producto (formatos, firma dibujada, emisión exigiendo firma, informes previos «Sin firma registrada», búsqueda y filtros) vinieron en la descripción del usuario y quedaron en Clarifications (sesión 2026-11-02); no quedan marcadores [NEEDS CLARIFICATION].
- Referencias técnicas mínimas en Assumptions (WeasyPrint, ya prevista en la constitución; `templates/ui/`), igual que en las specs 015 a 021, para la trazabilidad con la constitución y el diseño de SCRUM-67.
- FR-014 cambia la emisión de la US 7.2: después de esta historia, un bioquímico sin firma no puede emitir.
